Overdosing on Ibuprofen Causes Stomach Bleeding

Overdosing on Ibuprofen Causes Stomach Bleeding
TT

Overdosing on Ibuprofen Causes Stomach Bleeding

Overdosing on Ibuprofen Causes Stomach Bleeding

Many adults who use ibuprofen and other so-called nonsteroidal anti-inflammatory (NSAID) drugs take too much, increasing their risk of serious side effects like internal bleeding and heart attacks, a US study suggests.

About 15 percent of adults taking ibuprofen (Motrin, Advil) or other NSAIDs like aspirin, naproxen (Aleve), celecoxib (Celebrex), meloxicam (Mobic) and diclofenac (Voltaren) exceeded the maximum recommended daily dose for these drugs, the study found.

“NSAIDs are among the most commonly used medicines in the U.S. and worldwide,” said lead study author Dr. David Kaufman of Boston University.

“These drugs can have serious side effects, including gastrointestinal bleeding and heart attacks, and are often taken without medical oversight because many products are available over-the-counter,” Kaufman said by email. “The attitude that users can choose their own dose regardless of label directions, along with poor knowledge of dosing limits, is associated with exceeding the daily limit.”

For the study, 1,326 people who reported taking ibuprofen in the previous month completed online medication diaries every day for one week.

All of the participants took ibuprofen during the diary week, and 87 percent of them only used over-the-counter, or nonprescription, versions, researchers report in Pharmacoepidemiology & Drug Safety.

Overall, 55 percent of participants took ibuprofen at least three days during the week, and 16 percent took it every day.

In addition to ibuprofen, 37 percent of the participants reported taking at least one other NSAID during the week, most often aspirin or naproxen. Less than half of them recognized that all of the products they were taking were NSAIDs.

One limitation of the study is that researchers only focused on recent and current ibuprofen users, which may not reflect what doses might be typical for sporadic or new users, the authors note.

Even so, the findings highlight a potential downside of making NSAIDs widely available without a prescription, said Dr. Gunnar Gislason, director of research for the Danish Heart Foundation in Copenhagen.

“I believe that the message sent to the consumer when these drugs are widely available in convenience stores and gas stations is that these drugs are safe and you can use them safely for pain relief - thus no need for reading the label,” Gislason, who wasn’t involved in the study, said by email.

Even when people do read the label, they may still ignore it.

“If the recommended dosage does not give sufficient pain relief, it is easier to take more pills than seeking professional advice from a healthcare person or doctor,” Gislason added.

While doctors may prescribe NSAIDs for some muscle and joint disorders and certain other health problems, these drugs aren’t appropriate for many of the reasons that patients may buy them at the drugstore, said Dr. Liffert Vogt of the Academic Medical Center at the University of Amsterdam in the Netherlands.

“In my opinion NSAIDs should not be available as an over-the-counter drug, because of all their deleterious effects,” Vogt, who wasn’t involved in the study, said by email.

“For occasional use, acetaminophen (again in the right dose) is a much safer option and very efficacious as a painkiller,” Vogt added. “But we know that many people use NSAIDs for indications other than pain, such as flu, allergies, fever - and there is no medical base that indicates that NSAIDs or acetaminophen are of any use under these circumstances.”



Intuitive Machines' Athena Lander Closing in on Lunar Touchdown Site

A SpaceX Falcon 9 rocket lifts off from Launch Complex-39A carrying the Nova-C lunar lander Athena as part of NASA's Commercial Lunar Payload initiative from Kennedy Space Center in Cape Canaveral, Florida, US, February 26, 2025. REUTERS/Steve Nesius/File Photo
A SpaceX Falcon 9 rocket lifts off from Launch Complex-39A carrying the Nova-C lunar lander Athena as part of NASA's Commercial Lunar Payload initiative from Kennedy Space Center in Cape Canaveral, Florida, US, February 26, 2025. REUTERS/Steve Nesius/File Photo
TT

Intuitive Machines' Athena Lander Closing in on Lunar Touchdown Site

A SpaceX Falcon 9 rocket lifts off from Launch Complex-39A carrying the Nova-C lunar lander Athena as part of NASA's Commercial Lunar Payload initiative from Kennedy Space Center in Cape Canaveral, Florida, US, February 26, 2025. REUTERS/Steve Nesius/File Photo
A SpaceX Falcon 9 rocket lifts off from Launch Complex-39A carrying the Nova-C lunar lander Athena as part of NASA's Commercial Lunar Payload initiative from Kennedy Space Center in Cape Canaveral, Florida, US, February 26, 2025. REUTERS/Steve Nesius/File Photo

Intuitive Machines sent final commands to its uncrewed Athena spacecraft on Thursday as it closed in on a landing spot near the moon's south pole, the company's second attempt to score a clean touchdown after making a lopsided landing last year.

After launching atop a SpaceX rocket on Feb. 26 from Florida, the six-legged Athena lander has flown a winding path to the moon some 238,000 miles (383,000 km) away from Earth, where it will attempt to land closer to the lunar south pole than any other spacecraft.

The landing is scheduled for 12:32 pm ET (1732 GMT). It will target Mons Mouton, a flat-topped mountain some 100 miles (160 km) from the lunar south pole, Reuters reported.

Five nations have made successful soft landings in the past - the then-Soviet Union, the US, China, India and, last year, Japan. The US and China are both rushing to put their astronauts on the moon later this decade, each courting allies and giving their private sectors a key role in spacecraft development.

India's first uncrewed moon landing, Chandrayaan-3 in 2023, touched down near the lunar south pole. The region is eyed by major space powers for its potential for resource extraction once humans return to the surface - subsurface water ice could theoretically be converted into rocket fuel.

The Houston-based company's first moon landing attempt almost exactly a year ago, using its Odysseus lander, marked the most successful touchdown attempt at the time by a private company.

But its hard touchdown - due to a faulty laser altimeter used to judge its distance from the ground - broke a lander leg and caused the craft to topple over, dooming many of its onboard experiments.

Austin-based Firefly Aerospace this month celebrated a clean touchdown of its Blue Ghost lander, making the most successful soft landing by a private company to date.

Intuitive Machines, Firefly, Astrobotic Technology and a handful of other companies are building lunar spacecraft under NASA's Commercial Lunar Payload Services program, an effort to seed development of low-budget spacecraft that can scour the moon's surface before the US sends astronauts there around 2027.